Cargando…

Use of the Cardiovascular Polypill in Secondary Prevention of Cerebrovascular Disease: A Real-Life Tertiary Hospital Cohort Study of 104 Patients

BACKGROUND: The use of the cardiovascular polypill, a fixed-dose combination treatment, is conceived to improve adherence. However, randomized controlled trials (RCTs) may overestimate it. Studies focusing on cerebrovascular disease and real-life efficacy compared with conventional treatment are lac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ros-Castelló, Victoria, Natera-Villalba, Elena, Gómez-López, Ana, Sánchez-Sánchez, Arantxa, Chico-García, Juan Luis, García-Madrona, Sebastian, Vera-Lechuga, Rocio, Matute-Lozano, Consuelo, de Felipe Mimbrera, Alicia, Cruz-Culebras, Antonio, Alonso-Canovas, Araceli, Masjuan, Jaime
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747048/ https://www.ncbi.nlm.nih.gov/pubmed/33176324 http://dx.doi.org/10.1159/000511064

Ejemplares similares

Dabigatran in Secondary Stroke Prevention: Clinical Experience with 106 Patients
por: DeFelipe-Mimbrera, Alicia, et al.
Publicado: (2014)

Quality of Chronic Anticoagulation Control in Patients with Intracranial Haemorrhage due to Vitamin K Antagonists
por: Estevez-Fraga, Carlos, et al.
Publicado: (2018)

SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease
por: Gómez-López, Ana, et al.
Publicado: (2021)

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

The Polypill: From Promise to Pragmatism
por: Huffman, Mark D.
Publicado: (2015)

Polypill revisited – Unity in diversity
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2020)

The Attitude towards Polypills Questionnaire (APPQ): a phase I–III development and validation study in patients with cerebrovascular disease
por: Lehmann, Jens, et al.
Publicado: (2021)

Incobotulinumtoxin A for Sialorrhea in Neurological Disorders: A Real-Life Experience
por: Martínez-Poles, Javier, et al.
Publicado: (2018)

Cost-Effectiveness of the CNIC-Polypill Strategy Compared With Separate Monocomponents in Secondary Prevention of Cardiovascular and Cerebrovascular Disease in Portugal: The MERCURY Study
por: Aguiar, Carlos, et al.
Publicado: (2022)

Strengths and Limitations of Using the Polypill in Cardiovascular Prevention
por: Roy, Ambuj, et al.
Publicado: (2017)

Medicinal herbs: Potential polypills in cardiovascular diseases
por: Noroozi, Samaneh, et al.
Publicado: (2021)

The Benefits of Polypill: Adherence and Chronotherapy [Response to Letter]
por: Lopez-Jaramillo, Patricio, et al.
Publicado: (2023)

Statins alone or polypill for primary prevention of cardiovascular diseases
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2016)

Could patents interfere with the development of a cardiovascular polypill?
por: Beall, Reed F., et al.
Publicado: (2016)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
por: Sukonthasarn, Apichard, et al.
Publicado: (2020)

Redefining the polypill: pros and cons in cardiovascular precision medicine
por: Birla, Siddharth, et al.
Publicado: (2023)

„Polypill“ in der kardiovaskulären Prävention – erfolgreich durch Vereinfachung?: Neue Studienergebnisse zum Nutzen der Polypill-Strategie in der Primär- und Sekundärprävention
por: Despang, Patrick, et al.
Publicado: (2023)

Phosphorylation of Eukaryotic Initiation Factor 4G1 (eIF4G1) at Ser1147 Is Specific for eIF4G1 Bound to eIF4E in Delayed Neuronal Death after Ischemia
por: Martínez-Alonso, Emma, et al.
Publicado: (2022)

Impulse Control Disorders in Parkinson's Disease: Has COVID‐19 Related Lockdown Been a Trigger?
por: Rábano‐Suárez, Pablo, et al.
Publicado: (2021)

Randomized Polypill Crossover Trial in People Aged 50 and Over
por: Wald, David S., et al.
Publicado: (2012)

The Efficacy and Tolerability of ‘Polypills’: Meta-Analysis of Randomised Controlled Trials
por: Elley, C Raina, et al.
Publicado: (2012)

Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill
por: Lafeber, M., et al.
Publicado: (2016)

The polypill approach – An innovative strategy to improve cardiovascular health in Europe
por: Fuster, Valentín, et al.
Publicado: (2017)

Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia
por: Jung, Hae Won, et al.
Publicado: (2023)

The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
por: van Gils, Paul F, et al.
Publicado: (2011)

Prevention of Hypertensive Disorders of Pregnancy: a Novel Application of the Polypill Concept
por: Browne, J. L., et al.
Publicado: (2016)

Cost–benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke
por: Wald, Nicholas J., et al.
Publicado: (2016)

Process evaluation of the impact and acceptability of a polypill for prevention of cardiovascular disease
por: Wood, Frances, et al.
Publicado: (2015)

Polypill eligibility and equivalent intake in a Swiss population-based study
por: Castioni, Julien, et al.
Publicado: (2021)

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
por: Grigorian-Shamagian, Lilian, et al.
Publicado: (2021)

Adoption and scale-up of the cardiovascular Polypill: a realist institutional analysis
por: Abimbola, Seye, et al.
Publicado: (2022)

The cardiovascular polypill as baseline treatment improves lipid profile and blood pressure regardless of body mass index in patients with cardiovascular disease. The Bacus study
por: Chávez Fernández, José Alejandro, et al.
Publicado: (2023)

Cerebrovascular development: mechanisms and experimental approaches
por: Chico, Timothy J. A., et al.
Publicado: (2021)

Starting the polypill: the use of a single age cut-off in males and females
por: Wald, Nicholas J, et al.
Publicado: (2016)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
por: Kandil, Omneya A., et al.
Publicado: (2022)

Correlation of polypill and blood pressure level: A systematic review of clinical trials
por: Omrani, Hamidreza, et al.
Publicado: (2023)

Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk
por: Liu, Hueiming, et al.
Publicado: (2010)

Recruiting equal numbers of indigenous and non-indigenous participants to a ‘polypill’ randomized trial
por: Selak, Vanessa, et al.
Publicado: (2013)

The Effectiveness of Polypill for the Prevention of Cardiovascular Disease: A Meta-Analysis of Randomized Controlled Trials
por: Virk, Ghazala S, et al.
Publicado: (2023)

Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK
por: Becerra, Virginia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t2u0odlpj6p11vqj70fa6ggk7b